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Abstract
Introduction: Differentiated paediatric epithelial cells can be used to study the role of epithelial cells in asthma. Nasal
epithelial cells are easier to obtain and may act as a surrogate for bronchial epithelium in asthma studies. We assessed the
suitability of nasal epithelium from asthmatic children to be a surrogate for bronchial epithelium using air-liquid interface
cultures.
Methods: Paired nasal and bronchial epithelial cells from asthmatic children (n = 9) were differentiated for 28 days under
unstimulated and IL-13-stimulated conditions. Morphological and physiological markers were analysed using immunocy-
tochemistry, transepithelial-electrical-resistance, Quantitative Real-time-PCR, ELISA and multiplex cytokine/chemokine
analysis.
Results: Physiologically, nasal epithelial cells from asthmatic children exhibit similar cytokine responses to stimulation with
IL-13 compared with paired bronchial epithelial cells. Morphologically however, nasal epithelial cells differed significantly
from bronchial epithelial cells from asthmatic patients under unstimulated and IL-13-stimulated conditions. Nasal epithelial
cells exhibited lower proliferation/differentiation rates and lower percentages of goblet and ciliated cells when
unstimulated, while exhibiting a diminished and varied response to IL-13.
Conclusions: We conclude that morphologically, nasal epithelial cells would not be a suitable surrogate due to a
significantly lower rate of proliferation and differentiation of goblet and ciliated cells. Physiologically, nasal epithelial cells
respond similarly to exogenous stimulation with IL-13 in cytokine production and could be used as a physiological
surrogate in the event that bronchial epithelial cells are not available.
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Introduction
Airway epithelial cells not only provide a physical barrier to
potentially harmful insults but they also play a significant role in
the first line of immunological defence. There is increasing
evidence that allergic diseases such as asthma are associated with
epithelial disorders and, furthermore, that a primary abnormality
of the airway epithelium may be central to disease causation [1,2].
Chronic inflammation and airway remodelling are the main
characteristics of asthma however they have been observed to
occur in young children before asthma has become firmly
established [3,4]. In asthma, bronchial epithelial airway remod-
elling is characterised by goblet cell hyperplasia, reduced ciliated
cell numbers and mucus hypersecretion [5], defective repair and
proliferation [6], increased basal cell number [7] and impaired
barrier function [8,9].
Differentiated ALI cultures using the Transwell system have
recently been shown to be an authentic model representing the
airway epithelium ex vivo [10]. Differentiated ALI cultures from
healthy subjects displayed a polarised pseudostratified multi-layered
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epithelium comprising basal, ciliated and goblet cells whereas
cultures from asthmatic subjects displayed a dysfunctional epithe-
lium consistent with the asthmatic airway in vivo [5]. The cultures
closely mimic in vivo airway epithelial physiology in terms of cilia
coverage and cilial beating, mucus production and formation of
intact tight junctions [5,11].
Samples from the lower airways in children can be obtained at
the time of clinically indicated bronchoscopy but it is difficult to
justify sampling the lower airways in otherwise healthy control
children and in those with milder disease. The nasal epithelium
therefore represents an attractive alternative although it is unclear
how well the nasal epithelium represents the bronchial epithelium
in paediatric asthma. According to the ‘united airway concept’
there is a close connection between the upper and lower airways
[12–16]. This suggests that changes found in the nasal epithelium
might mirror similar changes occurring in the lower airways. The
link between allergic rhinitis and asthma has been underlined by
epidemiological and clinical studies [12–16] which suggest that
upper airway inflammation may reflect and provide an additional
insight into lower airway involvement. Devalia et al have
demonstrated that adult human nasal and bronchial epithelial
cells cultured in vitro resemble the cells in vivo [17]. These studies
involved using samples from adults and extrapolating data from
adult studies cannot accurately represent the paediatric epitheli-
um, especially since functional differences exist between adult and
paediatric epithelium [18]. Several studies have shown similar
morphology and response to cytokine stimulation between nasal
and bronchial epithelium using submerged monolayer cultures,
which only poorly represents the epithelium [19,20]. Differenti-
ated ALI cultures on the other hand are more authentic and can
be analysed for markers of differentiation including MUC5AC (the
major mucus-forming mucin) and SAM-pointed domain contain-
ing Ets-transcription factor (SPDEF) (a transcription factor in the
goblet cell hyperplasia pathway) production as well as for goblet
and ciliated cells and tight junction formation. As a result the
differentiated ALI culture model is the most appropriate platform
with which to conduct a comparison of paired nasal and bronchial
differentiated ALI cultures.
In this study we aimed to compare the morphological and
physiological profiles of nasal differentiated ALI cultures (PNECs)
with bronchial differentiated ALI cultures (PBECs) under basal
unstimulated and IL-13 stimulated conditions to determine the
ability of PNECs to act as an in vitro surrogate for PBECs in asthma
studies.
Methods
Subjects
Children less than 12 years of age (mean age 7.2 years [range: 1
to 12 years]) attending elective surgical procedures at the Royal
Belfast Hospital for Sick Children were recruited. A doctor
administered pro-forma was used to record the clinical history. Of
the nine children with atopic asthma, defined as recurrent
wheezing within the last year, 5 children had asthma plus allergic
rhinitis and 4 children had asthma plus eczema but no allergic
rhinitis (Table 1).
Ethics Statement
Written informed parental consent was obtained. This study
was approved by the Office of the Research Ethics Committees of
Northern Ireland (ORECNI).
Isolation of PBECs and PNECs
Primary bronchial epithelial cells were obtained from asthmatic
children as previously described [21]. Nasal brushings were
performed by rotating an endocervical brush in each nostril.
Asthmatic PBECs and asthmatic PNECs were cultured as
previously described [5]. All brush washings were analysed for
viruses using a multi-viral PCR analysis and only uncontaminated
cultures were used [22].
Differentiated ALI culture
ALI cultures (n = 9) were grown as previously described [5,11].
Briefly, cells from subjects used in this study were grown at ALI at
passage 2 for 28 days. At confluence, ALI was created by removing
the apical medium and restricting the culture feeding to the
basolateral compartment. The culture medium was changed on
alternate days during which the cells differentiated over 28 days to
ensure full differentiation as assessed by the presence of beating
cilia and mucus on the apical surface of the cultures. We sampled
12 patients in total however 3 of the cultures either did not
proliferate due to lack of cells from the initial sample or they did
not form a 100% confluent monolayer prior to differentiation and
so were rejected from the study.
Stimulation of PBECs and PNECs with IL-13
Following the establishment of ALI, cells were fed basolaterally
on alternate days with ALI medium [5] supplemented with
recombinant human IL-13 (PeProTech EC Ltd, UK) at 20 ng/ml
throughout the duration of the cultures (28 days) starting at day 0
ALI [11,23–30].
Transepithelial Electrical Resistance measurements (TEER)
We used TEER as a measure of ‘tight junction’ formation in
epithelial cultures [31]. TEER was measured weekly using an
EVOM meter (World Precision Instruments, FL, USA) [5,11].
Immunocytochemistry (ICC) for goblet and ciliated cell
markers
Cytospin slides were made for the detection of goblet and
ciliated cells from PBEC and PNEC cultures [5,11]. Negative
controls were subjected to routine conditions with the omission of
the primary antibody. The results are expressed as the percentage
differential goblet or ciliated cell count corrected for cell number
from 3 slides per stain per insert per patient.
RNA extraction and Quantitative Real-time PCR for
MUC5AC and SPDEF mRNA
RNA extraction and cDNA synthesis were carried out using the
RNeasy Mini kit (Qiagen, Crawley, UK) and First Strand cDNA
Synthesis Kit (AMV) (Roche, UK) according to the manufactur-
er’s protocol. Quantitative Real time PCR was carried out as
previously described [11].
Measurement of MUC5AC secreted apically using ELISA
Production of MUC5AC secreted mucin in the apical washes
from PBECs and PNECs was measured as previously described
[5,11] using an adapted in-house MUC5AC ELISA [32]. We used
mouse monoclonal antibody to MUC5AC [45M1] clone (Abcam,
UK) as the primary antibody and Goat anti-mouse IgG HRP
secondary antibody (Jackson Laboratories, USA) for detection of
primary antibody binding. Results are expressed as the optical
density corrected for MUC5AC positive control.
Nasal Epithelial Cells for Asthma Studies
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Cytokine Analysis
Apical washings and basolateral supernatants from unstimulated
and IL-13-stimulated PBECs and PNECs were analyzed using a
27-plex bead array assay (Bio-Plex Pro Human Cytokine 27-plex)
(BioRad, UK) as per manufacturers’ instructions. Results are only
shown for analytes that were within the limits of detection (IL-1ra,
IL-6, IL-7, IL-8, IL-12p70, granulocyte colony–stimulating factor
(G-CSF), granulocyte macrophage colony-stimulating factor (GM-
CSF), interferon gamma-induced protein 10 (IP-10), monocyte
chemoattractant protein-1 (MCP-1), regulated upon activation,
normal T cell expressed and secreted (RANTES) and vascular
endothelial growth factor (VEGF).
Statistical Analysis
Comparisons between PBECs and PNECs were made using
paired t-tests and repeated measures ANOVA, with logarithmic
transformation where appropriate. Cytokine concentrations were
corrected for total cell number (pg/cell) and then the fold change
in cytokine secretion following IL-13 stimulation was compared
with unstimulated cytokine secretion (IL-13-stimulated/unstimu-
lated). These results were then plotted on a log axis due to the
varying ranges of all analytes involved. Individual cytokine profiles
are included as supplemental data (Figures S1, S2, S3, S4, S5, S6)
along with additional detail on all of the mentioned methods in the
online data supplement (Methods S1).
Results
It is unlikely given the number of passages the cells go through
along with the length of time from sampling to completion of
culture (7–10 weeks) that there would be any carry-over effect of
inhaled corticosteriods in the following results.
TEER
We detected no overall differences in TEER values over time
under unstimulated conditions between PBECs and PNECs
[Figure 1A]. In contrast, following IL-13 stimulation, there was
a significant difference in TEER values on days 7 (p= 0.02) & 14
(p = 0.02) between PBECs and PNECs with the difference in
resistance becoming similar by days 21 & 28 [Figure 1B].
Total Cell Count
On day 28 we found a significantly higher total cell number
between PBECs [mean 5.76105 cells/ml (SD 1.2)] and PNECs
[mean 3.46105 cells/ml (SD 0.8), (p = 0.002)] under unstimulated
conditions [Table 2]. However there was no significant difference
in the total cell number under IL-13 stimulated conditions [PBECs
[mean 5.36105 cells/ml (SD 0.9); PNECs: mean 4.26105 cells/ml
(SD 1.1)] [Table 2]. All subsequent results have been adjusted for
total cell number.
Goblet Cell Quantification
IL-13 stimulation resulted in a similar increase in the percentage
of goblet cells in both PBECs [43.3% (SD 18.1), p = 0.0036] and
PNECs [19.4% (SD 4.0), p = 0.0001] compared with unstimulated
controls [PBEC: 27.1% (SD 18.4); PNEC: 8.4% (SD 2.4)]
[Figure 2]. In addition there was a significant difference in goblet
cell percentage between PNEC unstimulated and PBEC unstimu-
lated [8.4% (SD 2.4) versus 27.1% (SD 18.4) respectively,
p = 0.033] and PNEC IL-13 stimulated and PBEC IL-13
stimulated [19.4% (SD 4.0) versus 43.3% SD (18.1) respectively,
p = 0.009].
Real Time PCR
SPDEF mRNA was higher in IL-13 stimulated PNECs
(p = 0.013) and IL-13 stimulated PBECs (p = 0.02) compared with
unstimulated PNECs and PBECs demonstrating a similar response
to exogenous stimulation between PBECs and PNECs [Figure 3A].
However under IL-13 stimulation there was a similar level of
MUC5AC mRNA between stimulated and unstimulated PNECs
whereas IL-13 stimulated PBECs had higher levels of MUC5AC
mRNA than unstimulated PBECs (p = 0.04) [Figure 3B].
Measurement of MUC5AC secreted apically using ELISA
Under IL-13 stimulation similar quantities of apically secreted
mucin were measured between PNECs and PBECs [Figure 3C].
Ciliated Cell Quantification
IL-13 stimulated PBECs had lower ciliated cell numbers than
unstimulated PBECs [5.9% (SD 1.6) versus 14.8% (SD 2.5)
respectively, p= 0.005] which was not observed between PNEC
IL-13 stimulated and PNEC unstimulated [2.8% (SD 3.4) versus
3.5% (SD 1.7) respectively] [Figure 4]. There was a significant
difference between PBEC unstimulated and PNEC unstimulated
[14.8% (SD 2.5) versus 3.5% (SD 1.7) respectively, p = 0.0001]
[Figure 4]. In addition there was a significant difference between
PBEC IL-13 stimulated and PNEC IL-13 stimulated [5.9% (SD
1.6) versus 2.8% (SD 3.4) respectively, p = 0.002] [Figure 4].
Table 1. Patient details including clinical status and clinical atopy.
Clinical Status Clinical Atopy (assessed by questionnaire) Serum IgE Concentration (kU/L) Age (y) Gender (M/F) Treatment
Asthmatic Allergic Rhinitis, Allergic Conjunctivitis 2258 6 M ICS/LABA, LTA
Asthmatic Eczema 154 7 M ICS/LABA
Asthmatic Eczema 446 4 F SABA, when required
Asthmatic Eczema, Allergic Rhinitis 5158 12 M ICS/LABA
Asthmatic Allergic Rhinitis 101 9 M ICS/LABA
Asthmatic Eczema 10 2 M ICS, SABA
Asthmatic Eczema 627 7 M ICS/LABA
Asthmatic Eczema, Allergic Rhinitis 100 11 M ICS
Asthmatic Allergic Rhinitis 40 1 M ICS
Current treatment abbreviations are classed as follows: inhaled corticosteroid (ICS), long-acting beta agonist (LABA), short-acting beta agonist (SABA) and leukotriene
antagonist (LTA).
doi:10.1371/journal.pone.0085802.t001
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Cytokine production from PBECs and PNECs
Analytes that were within the limits of detection were IL-1ra,
IL-6, IL-7, IL-8, IL-12p70, granulocyte colony–stimulating factor
(G-CSF), granulocyte macrophage colony-stimulating factor (GM-
CSF), interferon gamma-induced protein 10 (IP-10), monocyte
chemoattractant protein-1 (MCP-1), regulated upon activation,
normal T cell expressed and secreted (RANTES) and vascular
endothelial growth factor (VEGF). The fold change of apically
secreted cytokines after IL-13 stimulation [Figure 5A] showed
there to be no significant difference between PBECs and PNECs.
Similarly, there was no significant difference in basolaterally
secreted cytokines between PBECs and PNECs stimulated with
IL-13 [Figure 5B] demonstrating an overall similar response to IL-
13 stimulation between PNECs and PBECs. Individual cytokine
secretion graphs are included in the supplementary data section of
this paper.
Discussion
Nasal epithelial cells provide an attractive alternative to
bronchial epithelial cells for use in asthma research due to their
accessibility without the need for anaesthesia and intubation
however it is unclear whether differentiated nasal ALI cultures
represent the differentiated bronchial ALI cultures morphologi-
cally and physiologically. We have compared paired nasal and
bronchial epithelial cells differentiated at ALI from asthmatic
children in order to determine whether nasal epithelial cells can
act as a surrogate for bronchial epithelial cells. We have found that
PNECs exhibit different morphological features such as lower
proliferation rates and differentiation of goblet and ciliated cells
compared with PBECs however their physiological response of
secreted cytokines to exogenous stimulation with IL-13, a key
cytokine in the pathogenesis of asthma is strikingly similar when
corrected for cell number.
In considering morphology, unstimulated PNECs do not exhibit
the constitutive goblet cell hyperplasia seen in unstimulated
PBECs [5]. This is to be expected as asthma is a lower airways
disease. Mouse models of allergic rhinitis have reported that a
goblet cell hyperplasia may only exist following stimulation with
ovalbumin [33,34] or TGF-b [35]. IL-13 has been shown to
increase goblet cell hyperplasia in non-asthmatic and asthmatic
paediatric bronchial epithelium [11] and in this study we have
shown that PNECs also respond with a goblet cell increase to IL-
13 stimulation along with a significant increase in SAM-pointed
domain-containing Ets-like factor (SPDEF) mRNA which is
implicated in the goblet cell hyperplasia pathway [36]. Miyahara
and colleagues found that although IL-13 is a major contributor to
the late nasal response it did not induce a goblet cell hyperplasia
[37] however our data is at odds with this finding. The IL-13
mediated reduction of ciliated cells in PBECs is not observed with
IL-13 stimulation in PNECs however.
In a previous study by McDougall et al. which compared
bronchial and nasal epithelial monolayers from adults and
children they found the cells to look morphologically similar
[19]. However, differentiated nasal ALI cultures display notable
morphological differences when compared with the differentiated
bronchial ALI cultures which could not have been detected in
submerged monolayer cultures. We found that PNECs did not
proliferate or differentiate at the same rate as PBECs with a
significant lower total cell number at the end of the culture period
Figure 1. Measurement of Transepithelial Electrical Resistance (TEER). A - TEER of unstimulated PNECs and PBECs cultured for 28 d. Values
are expressed as mean 6 SD. No significant difference was observed in the TEER values between the groups. B - TEER of PNECs and PBECs cultured
with 20 ng/ml IL-13 for 28 d. Values are expressed as mean 6 SD. On days 7 and 14 there was a significant difference in TEER values between PNECs
and PBECs (p,0.02 for each time point) however by the end of the culture period the TEER values were similar between groups.
doi:10.1371/journal.pone.0085802.g001
Table 2. Total cell count on day 28 of ALI culture.
Sample Mean number of cells (6105 cells/ml) Standard Deviation P value Treatment
PBEC(A) 5.7 1.2 0.002 Unstimulated
PNEC(A) 3.4 0.8 Unstimulated
PBEC(A) 5.3 0.9 .0.05 20 ng/ml IL-13
PNEC(A) 4.2 1.1 20 ng/ml IL-13
Under unstimulated conditions there were significant differences between PBECs and PNECs (p = 0.002). However under IL-13 stimulated conditions there were no
significant differences between the same groups.
doi:10.1371/journal.pone.0085802.t002
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Figure 2. Quantification of Goblet Cell Number. Number of
goblet cells from PNECs and PBECs treated with 20 ng/ml IL-13
expressed as the percentage differential goblet cell count corrected for
cell number on d 28 of ALI culture. Comparisons of average values
between groups were performed using paired t-tests. There was a
significant difference seen between unstimulated and IL-13 stimulated
PNECs (p = 0.0001) and in IL-13 stimulated PBECs when compared to
unstimulated PBECs (p = 0.0036). Additionally, there was a significant
difference between PNEC unstimulated and PBEC unstimulated
(p = 0.033) and when cells where stimulated with IL-13, the percentage
of goblet cells was significantly higher in stimulated PBECs compared to
stimulated PNECs (p = 0.009).
doi:10.1371/journal.pone.0085802.g002
Figure 3. Gene expression of SPDEF & MUC5AC mRNA and ELISA for MUC5AC mucin secretion. A - Gene expression of SPDEF mRNA
using comparative quantitation real time PCR in IL-13 stimulated PNECs and PBECs expressed as fold change compared to unstimulated cells. In both
cell types, stimulation with IL-13 caused a significant increase in SPDEF mRNA levels (PNECs: p = 0.013; PBECs: p = 0.02). B - Gene expression of
MUC5AC mRNA using comparative quantitation real time PCR in IL-13 stimulated PNECs and PBECs expressed as fold change compared to
unstimulated cells. There was no significant increase in MUC5AC mRNA levels in PNECs, however, stimulation with IL-13 caused a significant increase
in MUC5AC mRNA levels in PBECs (p = 0.04). C - Relative optical density (OD l= 450 nm) of MUC5AC secreted apically using ELISA corrected for
MUC5AC positive control. There was no significant difference between unstimulated and IL-13 stimulated PNECs or PBECs.
doi:10.1371/journal.pone.0085802.g003
Figure 4. Quantification of Ciliated Cells. Number of ciliated cells
from PNECs and PBECs treated with 20 ng/ml IL-13 expressed as the
percentage differential ciliated cell count corrected for cell number on d
28 of ALI culture. Comparisons of average values between groups were
performed using paired t-tests. In unstimulated conditions, PBEC
cultures contained a significantly higher percentage of ciliated cells
than PNECs (p = 0.0001). However, when stimulated with IL-13, the
percentage of ciliated cells significantly decreased in PBECs (p = 0.005),
but IL-13 had no effect on ciliated cell numbers in PNECs. Additionally,
IL-13 stimulated PBECs had significantly higher numbers of ciliated cells
compared with IL-13 stimulated PNECs (p = 0.002).
doi:10.1371/journal.pone.0085802.g004
Nasal Epithelial Cells for Asthma Studies
PLOS ONE | www.plosone.org 5 January 2014 | Volume 9 | Issue 1 | e85802
in addition to the differences seen in goblet and ciliated cells under
basal and stimulated conditions. PBECs appeared to exhibit
consistent distinct morphological changes in response to IL-13
stimulation whereas PNECs responded in a variable manner. We
did however observe some similarities between PBECs and
PNECs: TEER measurements, which is at odds with the TEER
data generated by Lopez-Souza and colleagues [38] and
MUC5AC secretion under unstimulated conditions. Taken
together, morphologically there does not appear to be enough
consistency between PBECs and PNECs which would suggest that
for studies focussing on the morphology of the asthmatic bronchial
epithelium, PNECs would not serve as an appropriate surrogate.
In considering physiological response we examined the effects of
an exogenous cytokine, namely IL-13, on cytokine/mediator
release from PBECs and PNECs and found a similar response
profile when corrected for cell number. McDougall et al. found
that constitutive and cytokine-stimulated release of particular
cytokines (IL-6, IL-8, MMP-9 and RANTES) was significantly
higher in nasal monolayer than bronchial monolayer cultures but
that on further analysis nasal and bronchial epithelial cells
responded in the same way showing significant correlation [19].
In a follow-up study from the same group, looking specifically at
mediator release between nasal and bronchial epithelial monolay-
er cultures from children, Pringle and colleagues found that
RANTES, MMP-9, TIMP-1, MCP-1 and VEGF were similar
between nasal and bronchial monolayer cultures whereas IL-6, IL-
8 and G-CSF were higher [20]. The difference in observations of
MMP-9 and RANTES between the studies is proposed to be due
to the first study having a mixed population of adult and paediatric
epithelial cells. We demonstrated a similar finding to McDougall et
al. and Pringle et al. in those cytokines from our panel that were
detectable. Both PNECs and PBECs responded to IL-13
stimulation (corrected for cell numbers) in a similar manner,
albeit with PNECs generally expressing higher levels of cytokine.
This would suggest that physiologically for the cytokines
measured, PNECs could be used as a surrogate for PBECs.
Further studies would hope to confirm this observation however it
would suggest that the similarities seen in monolayer mediator
release are maintained throughout the differentiation process.
In a more recent study using well-differentiated paediatric
asthmatic and non-asthmatic paired bronchial and nasal epithelial
cells, Lopez-Guisa and colleagues also suggested that there was
correlation in mediator release between PBEC and PNEC cultures
[39]. This group showed TGF-b2 and VEGF to be significantly
increased in asthmatic bronchial and nasal epithelium compared
to non-asthmatic under unstimulated conditions. TGF-b2 and
periostin were significantly up-regulated in nasal and bronchial
asthmatic epithelium under unstimulated and following IL-4/IL-
13 stimulation [39]. Unfortunately our study did not have a
sample of non-asthmatic children to perform a similar comparison.
However, our study broadly agrees with Lopez-Guisa et al. in
terms of the similarities observed in mediator release between
nasal and bronchial asthmatic epithelium.
IL-13 resulted in the reduction of the majority of cytokines, with
the exceptions of IL-8 and VEGF, when secreted apically and
basolaterally and GM-CSF when secreted basolaterally. Surpris-
ingly, a number of cytokines that we expected to increase actually
decreased including IL-1ra, GM-CSF and MCP-1 [40–43]. While
there are various studies that have noted increases in these
cytokines under stimulation with IL-13 we would add that many
used different culture systems, stimulation concentrations and
treatment regimens compared to our study, which may go some
way to explaining the unexpected decrease in these mediators. We
believe this is a true reflection of the epithelium as in both PBECs
and PNECs we saw strikingly similar responses to our chronic
stimulation.
Our data confirm that characteristics and responses in
submerged monolayer cultures differ from differentiated ALI
cultures. We believe that our differentiated ALI model authenti-
cally represents the true state of the epithelium in vivo [10]. A
recent study by Ogilvie and colleagues, who compared paired CF
nasal and bronchial epithelial brushings using microarray, found
Figure 5. Cytokine Analysis of Apical Washings and Basolateral Supernatants using Bioplex. A – Apical secretion of cytokines in PBEC
and PNEC cultures. Results were corrected for cell numbers and a fold change ratio was calculated (IL-13 stimulated/unstimulated). In order to
graphically represent all detectable cytokines the results were plotted on a logarithmic axis. There were no significant differences in any of the
detected cytokines secreted between PNECs and PBECs. B - Basolateral secretion of cytokines in PBEC and PNEC cultures. Results were corrected for
cell number and a fold change ratio was then calculated (IL-13 stimulated/unstimulated). In order to graphically represent all detectable cytokines the
results were plotted on a logarithmic axis. There were no significant differences in any of the cytokines secreted between PNECs and PBECs.
doi:10.1371/journal.pone.0085802.g005
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that differences in the global gene expression profiles of CF and
non-CF nasal and bronchial epithelial cells existed. They
recommended not using nasal epithelial cells as a surrogate for
pre-screening prior to lung-directed therapies [44]. Whether nasal
epithelium should be used in place of bronchial epithelium will
inevitably be determined by the focus and design of future studies
and with a growing literature on the many comparisons now
taking place, we will be much better informed of the benefits or
drawbacks of using nasal as a surrogate for bronchial epithelial
cells.
Our study was limited in a number of ways. Firstly, we were
unable to sample a large enough number of non-asthmatic
controls to perform a comparison between health and disease.
Secondly, in terms of stimulation only one cytokine (IL-13) was
used due to the quantity of cells available. It would be interesting
to know if other stimuli in PNECs reflect the response in PBECs.
Additional studies are required to further explore the use of nasal
epithelial cells as a surrogate.
In conclusion, we have demonstrated that our models of
differentiated PNECs and PBECs display notable morphological
differences which would question the use of PNECs as a reliable
and reproducible morphological surrogate, especially in asthma
where characteristic traits such as constitutive goblet cell
hyperplasia are absent in PNECs from asthmatics. However, we
have also demonstrated that physiologically, both PNECs and
PBECs respond in the same way to stimulation with IL-13
suggesting that PNECs could be used as a physiological surrogate
for PBECs in asthmatic studies in the event that bronchial
epithelial cells are not available.
Supporting Information
Figure S1 Cytokine analysis of IL-1ra, IL-6, IL-7 & IL-8
secreted apically. A - Analysis of IL-1ra secreted apically using
the Bioplex system. Results were corrected for cell number and
absolute concentrations plotted in pg/cell. IL-13 stimulated
PNECs and PBECs secreted significantly less IL-1ra compared
with unstimulated PNECs (p = 0.02) and PBECs (p = 0.001).
Additionally unstimulated PNECs secreted higher levels of IL-
1ra compared with unstimulated PBECs (p = 0.04). B - Analysis of
IL-6 secreted apically using the Bioplex system. Results were
corrected for cell number and absolute concentrations plotted in
pg/cell. IL-13 stimulated PNECs and PBECs secreted significantly
less IL-6 compared with unstimulated PNECs (p = 0.02) and
PBECs (p= 0.01). Additionally unstimulated PNECs secreted
higher levels of IL-6 compared with unstimulated PBECs
(p = 0.04). C - Analysis of IL-7 secreted apically using the Bioplex
system. Results were corrected for cell number and absolute
concentrations plotted in pg/cell. IL-13 stimulated PNECs and
PBECs secreted significantly less IL-7 compared with unstimulated
PNECs (p= 0.0003) and PBECs (p = 0.0004). Additionally un-
stimulated PNECs secreted higher levels of IL-7 compared with
unstimulated PBECs (p = 0.04). D - Analysis of IL-8 secreted
apically using the Bioplex system. Results were corrected for cell
number and absolute concentrations plotted in pg/cell. IL-13
stimulated PNECs and PBECs secreted higher levels of IL-8
compared with unstimulated PNECs and PBECs however they did
not reach statistical significance. Additionally IL-13 stimulated
PNECs secreted higher levels of IL-8 compared with IL-13
stimulated PBECs (p = 0.03).
(TIF)
Figure S2 Cytokine analysis of IL-12p70, G-CSF, IP-10 &
MCP-1 secreted apically. A - Analysis of IL-12p70 secreted
apically using the Bioplex system. Results were corrected for cell
number and absolute concentrations plotted in pg/cell. IL-13
stimulated PNECs and PBECs secreted significantly less IL-12p70
compared with unstimulated PNECs (p= 0.007) and PBECs
(p = 0.0009). Additionally unstimulated PNECs secreted higher
levels of IL-12p70 compared with unstimulated PBECs although
this was not statistically significant (p = 0.08). B - Analysis of G-
CSF secreted apically using the Bioplex system. Results were
corrected for cell number and absolute concentrations plotted in
pg/cell. IL-13 stimulated PNECs secreted significantly less G-CSF
compared with unstimulated PNECs (p= 0.03). There was no
significant difference between IL-13 stimulated and unstimulated
PBECs. Additionally unstimulated PNECs secreted higher levels of
G-CSF compared with unstimulated PBECs although this was not
statistically significant. C - Analysis of IP-10 secreted apically using
the Bioplex system. Results were corrected for cell number and
absolute concentrations plotted in pg/cell. IL-13 stimulated
PNECs and PBECs secreted lower levels of IP-10 compared with
unstimulated PNECs (p= 0.006) and PBECs (p = 0.01). Addition-
ally unstimulated PNECs secreted significantly higher levels of IP-
10 compared with unstimulated PBECs (p = 0.047) and IL-13
stimulated PNECs secreted higher levels of IP-10 compared with
IL-13 stimulated PBECs (p = 0.04). D - Analysis of MCP-1
secreted apically using the Bioplex system. Results were corrected
for cell number and absolute concentrations plotted in pg/cell. IL-
13 stimulated PNECs and PBECs secreted lower levels of MCP-1
compared with unstimulated PNECs (p= 0.005) and PBECs
(p = 0.01). Additionally unstimulated PNECs secreted significantly
higher levels of IP-10 compared with unstimulated PBECs
(p = 0.001).
(TIF)
Figure S3 Cytokine analysis of RANTES, VEGF & GM-
CSF secreted apically. A - Analysis of RANTES secreted
apically using the Bioplex system. Results were corrected for cell
number and absolute concentrations plotted in pg/cell. IL-13
stimulated PNECs and PBECs secreted lower levels of RANTES
compared with unstimulated PNECs (p= 0.003) and PBECs
(p = 0.049). Additionally unstimulated PNECs secreted significant-
ly higher levels of RANTES compared with unstimulated PBECs
(p = 0.047). B - Analysis of VEGF secreted apically using the
Bioplex system. Results were corrected for cell number and
absolute concentrations plotted in pg/cell. There was no
significant difference between IL-13 stimulated PNECs and
PBECs compared with unstimulated PNECs and PBECs or
between PNECs and PBECs. C - Analysis of GM-CSF secreted
apically using the Bioplex system. Results were corrected for cell
number and absolute concentrations plotted in pg/cell. IL-13
stimulated PNECs secreted lower levels of GM-CSF compared
with unstimulated PNECs (p = 0.009). There was no significant
change in GM-CSF between IL-13 stimulated and unstimulated
PBECs. Additionally unstimulated PNECs secreted significantly
higher levels of GM-CSF compared with unstimulated PBECs
(p = 0.01).
(TIF)
Figure S4 Cytokine analysis of IL-1ra, IL-6, IL-7 & IL-8
secreted basolaterally. A - Analysis of IL-1ra secreted
basolaterally using the Bioplex system. Results were corrected
for cell number and absolute concentrations plotted in pg/cell. IL-
13 stimulated PNECs secreted significantly less IL-1ra compared
with unstimulated PNECs (p = 0.04). There was no significant
difference between IL-13 stimulated and unstimulated PBECs.
Additionally there was no difference in IL-1ra secretion between
PNECs and PBECs. B - Analysis of IL-6 secreted basolaterally
using the Bioplex system. Results were corrected for cell number
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and absolute concentrations plotted in pg/cell. IL-13 stimulated
PNECs secreted less IL-6 compared with unstimulated PNECs
however, this did not reach statistical significance. There was a
significant difference in IL-6 secretion between IL-13 stimulated
and unstimulated PBECs (p = 0.04). Additionally the IL-13
stimulated PNECs secreted higher levels of IL-1ra compared with
IL-13 stimulated PBECs (p= 0.04). C - Analysis of IL-7 secreted
basolaterally using the Bioplex system. Results were corrected for
cell number and absolute concentrations plotted in pg/cell. IL-13
stimulated PNECs and PBECs secreted less IL-7 compared with
unstimulated PNECs (p = 0.06) and PBECs (p = 0.05) but these did
not reach statistical significance. Additionally there was no
significant difference in IL-7 secretion between PBECs and
PNECs. D - Analysis of IL-8 secreted basolaterally using the
Bioplex system. Results were corrected for cell number and
absolute concentrations plotted in pg/cell. There was no
significant difference in IL-8 secretion between IL-13 stimulated
PNECs and PBECs compared with unstimulated PNECs and
PBECs or between PNECs and PBECs.
(TIF)
Figure S5 Cytokine analysis of IL-12p70, G-CSF, IP-10 &
MCP-1 secreted basolaterally. A - Analysis of IL-12p70
secreted basolaterally using the Bioplex system. Results were
corrected for cell number and absolute concentrations plotted in
pg/cell. There was no significant difference between IL-13
stimulated PNECs and PBECs compared with unstimulated PNECs
and PBECs. However unstimulated PNECs secreted higher levels of
IL-12p70 compared with unstimulated PBECs (p= 0.009). B -
Analysis of G-CSF secreted basolaterally using the Bioplex system.
Results were corrected for cell number and absolute concentrations
plotted in pg/cell. There was no significant difference between IL-
13 stimulated PNECs and PBECs compared with unstimulated
PNECs and PBECs although there was a large decrease in
concentration. However IL-13 stimulated PNECs secreted higher
levels of IL-12p70 compared with IL-13 stimulated PBECs
(p= 0.048). C - Analysis of IP-10 secreted basolaterally using the
Bioplex system. Results were corrected for cell number and absolute
concentrations plotted in pg/cell. There was no significant
difference between IL-13 stimulated PNECs and PBECs compared
with unstimulated PNECs and PBECs. However unstimulated
PNECs secreted higher levels of IP-10 compared with unstimulated
PBECs (p= 0.009). D - Analysis of MCP-1 secreted basolaterally
using the Bioplex system. Results were corrected for cell number
and absolute concentrations plotted in pg/cell. There was lower
MCP-1 secretion between IL-13 stimulated PNECs and PBECs
compared with unstimulated PNECs and PBECs however this did
not reach statistical significance. Unstimulated PNECs secreted
significantly higher levels of MCP-1 compared with unstimulated
PBECs (p= 0.003) as did IL-13 stimulated PNECs compared with
IL-13 stimulated PBECs which was close to reaching significance
(p= 0.05).
(TIF)
Figure S6 Cytokine analysis of RANTES, VEGF & GM-
CSF secreted basolaterally. A - Analysis of RANTES secreted
basolaterally using the Bioplex system. Results were corrected for
cell number and absolute concentrations plotted in pg/cell. There
was no significant difference between IL-13 stimulated PNECs and
PBECs compared with unstimulated PNECs and PBECs or
between PNECs and PBECs. B - Analysis of VEGF secreted
basolaterally using the Bioplex system. Results were corrected for
cell number and absolute concentrations plotted in pg/cell. There
was no significant difference between IL-13 stimulated PNECs and
PBECs compared with unstimulated PNECs and PBECs or
between PNECs and PBECs. C - Analysis of GM-CSF secreted
basolaterally using the Bioplex system. Results were corrected for
cell number and absolute concentrations plotted in pg/cell. IL-13
stimulated PNECs secreted significantly more GM-CSF compared
with unstimulated PNECs (p = 0.039). Additionally there was no
significant difference in GM-CSF secretion between IL-13
stimulated and unstimulated PBECs or between PBECs and
PNECs.
(TIF)
Methods S1 Full descriptions of each method used in
the study are provided in the supplementary methods
section.
(DOC)
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